BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28861795)

  • 1. Strain Typing of Prion Diseases Using In Vivo Mouse Models.
    Boyle A; Hogan K; Manson JC; Diack AB
    Methods Mol Biol; 2017; 1658():263-283. PubMed ID: 28861795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Quick Method to Evaluate the Effect of the Amino Acid Sequence in the Misfolding Proneness of the Prion Protein.
    Fernández-Borges N; Eraña H; Elezgarai SR; Harrathi C; Venegas V; Castilla J
    Methods Mol Biol; 2017; 1658():205-216. PubMed ID: 28861792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future.
    Parchi P; Strammiello R; Giese A; Kretzschmar H
    Acta Neuropathol; 2011 Jan; 121(1):91-112. PubMed ID: 21107851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structuring the puzzle of prion propagation.
    Eghiaian F
    Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
    Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
    PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards further reduction and replacement of animal bioassays in prion research by cell and protein misfolding cyclic amplification assays.
    Boerner S; Wagenführ K; Daus ML; Thomzig A; Beekes M
    Lab Anim; 2013 Apr; 47(2):106-15. PubMed ID: 23479773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology and pathology of prion strains in sporadic human prion diseases.
    Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
    Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy.
    Bartz JC; Bessen RA; McKenzie D; Marsh RF; Aiken JM
    J Virol; 2000 Jun; 74(12):5542-7. PubMed ID: 10823860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
    Weissmann C; Fischer M; Raeber A; Büeler H; Sailer A; Shmerling D; Rülicke T; Brandner S; Aguzzi A
    Int J Exp Pathol; 1996 Dec; 77(6):283-93. PubMed ID: 9155663
    [No Abstract]   [Full Text] [Related]  

  • 11. Prion infection: seeded fibrillization or more?
    Birkmann E; Riesner D
    Prion; 2008; 2(2):67-72. PubMed ID: 19098436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurometals in the Pathogenesis of Prion Diseases.
    Kawahara M; Kato-Negishi M; Tanaka KI
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse models of prion diseases.
    Telling GC
    Methods Mol Biol; 2008; 459():249-63. PubMed ID: 18576160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the possibility to protect bovine PrPC transgenic Swiss mice against bovine PrPSc infection by DNA vaccination using recombinant plasmid vectors harboring and expressing the complete or partial cDNA sequences of bovine PrPC.
    Müller S; Kehm R; Handermann M; Jakob NJ; Bahr U; Schröder B; Darai G
    Virus Genes; 2005 Mar; 30(2):279-96. PubMed ID: 15744583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomedicine. A view from the top--prion diseases from 10,000 feet.
    Priola SA; Chesebro B; Caughey B
    Science; 2003 May; 300(5621):917-9. PubMed ID: 12738843
    [No Abstract]   [Full Text] [Related]  

  • 16. Prion infection of mouse neurospheres.
    Giri RK; Young R; Pitstick R; DeArmond SJ; Prusiner SB; Carlson GA
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3875-80. PubMed ID: 16495413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.
    Yoshioka M; Imamura M; Okada H; Shimozaki N; Murayama Y; Yokoyama T; Mohri S
    Microbiol Immunol; 2011 May; 55(5):331-40. PubMed ID: 21362027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods of Protein Misfolding Cyclic Amplification.
    Makarava N; Savtchenko R; Baskakov IV
    Methods Mol Biol; 2017; 1658():169-183. PubMed ID: 28861790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-genetic propagation of strain-specific properties of scrapie prion protein.
    Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
    Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.